Tomokazu Ichikawa

Marunouchi Office
Admitted in Japan

He is an attorney specializing in M&A, corporate law, and cross-border transactions, with particular expertise in the healthcare sector. He has extensive experience originating and executing investment and M&A transactions internationally,
having led numerous cross-border deals as an investment professional. He has also supported post-merger integration initiatives, including enhancing the governance of acquired companies. In addition to advising start-ups on strategic and financing matters, he currently serves as a board director of a
medical technology start-up and previously held a non-executive directorship at a healthcare service provider in India. His practice also includes advising financial institutions, listed manufacturers, and emerging companies on M&A, investment, and due diligence, with a strong focus on healthcare and medical technology.

Practice Areas
M&A, Corporate, Fund

Language
Japanese, English

12/2022-Current Director at AI Medical Singapore Pte., Ltd.
04/2021-05/2022 Genting Singapore
07/2017-04/2021 Non-executive director at Eye-Q Vision Private Limited
04/2016-04/2021 Hoya Corporation, Singapore Branch
03/2012-03/2016 Mizuho Bank, Singapore Branch
10/2010-01/2012 McKinsey and Company
10/2003-08/2010 Nagashima, Ohno & Tsunematsu, Attorneys-at-Law
09/2010 MBA, University of Cambridge
09/2009 MSc in Finance, London Business School
03/2022 BA in Commerce, Waseda University